Texas Capital Bancshares (TCBIO) Stock Analysis & Price (Updated Oct 15, 2026, 4:00 PM ET)
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.98, -7.27% vs the prior close of $19.39.
- Volume 6.57K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TCBIO slides 7.3% to $17.98. Closed at $17.98, -7.27% vs the prior close of $19.39. Day range $17.30–$18.06, opened at $17.50.
TCBIO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TCBIO slides 7.3% to $17.98
- Closed at $17.98, -7.27% vs the prior close of $19.39. Day range $17.30–$18.06, opened at $17.50.
- Volume was 6.57K shares, 1.0x its 50-day average of 6.88K.
- 52-week range $17.30–$19.39; today's close sits at 33% of that range, 7.3% below the 52-week high.
Oct 14, 2026 — TCBIO jumps 6.0% to $19.39
- Closed at $19.39, +5.96% vs the prior close of $18.30. Day range $17.41–$19.39, opened at $18.25.
- Volume was 4.91K shares, 0.7x its 50-day average of 7.27K.
- 52-week range $17.41–$19.39; today's close sits at 100% of that range, at a new 52-week high.
Oct 13, 2026 — TCBIO rises 1.0% to $18.30
- Closed at $18.30, +0.99% vs the prior close of $18.12. Day range $17.95–$18.30, opened at $18.00.
- Volume was 1.21K shares, 0.1x its 50-day average of 8.79K — lighter than usual.
- 52-week range $17.95–$19.24; today's close sits at 27% of that range, 4.9% below the 52-week high.
Oct 12, 2026 — TCBIO dips 0.7% to $18.12
- Closed at $18.12, -0.71% vs the prior close of $18.25. Day range $18.00–$18.45, opened at $18.10.
- Volume was 1.27K shares, 0.1x its 50-day average of 11.29K — lighter than usual.
- 52-week range $18.00–$19.24; today's close sits at 10% of that range, 5.8% below the 52-week high.
Oct 9, 2026 — TCBIO dips 1.4% to $18.25
- Closed at $18.25, -1.40% vs the prior close of $18.51. Day range $18.10–$18.26, opened at $18.26.
- Volume was 7.85K shares, 0.6x its 50-day average of 13.01K.
- 52-week range $18.07–$19.24; today's close sits at 15% of that range, 5.1% below the 52-week high.
Oct 8, 2026 — TCBIO rises 1.3% to $18.51
- Closed at $18.51, +1.26% vs the prior close of $18.28. Day range $18.14–$19.24, opened at $18.14.
- Volume was 1.45K shares, 0.1x its 50-day average of 24.57K — lighter than usual.
- 52-week range $18.07–$19.24; today's close sits at 38% of that range, 3.8% below the 52-week high.
Oct 7, 2026 — TCBIO dips 1.2% to $18.28, a 3-month low, 3 down days in a row
- Closed at $18.28, -1.19% vs the prior close of $18.50. Day range $18.07–$18.45, opened at $18.45.
- Volume was 24.57K shares, 1.1x its 50-day average of 21.52K.
- Price is -8.0% vs its 50-day average ($19.88).
- 52-week range $17.96–$20.91; today's close sits at 11% of that range, 12.6% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — TCBIO dips 2.0% to $18.50
- Closed at $18.50, -1.99% vs the prior close of $18.88. Day range $18.47–$19.05, opened at $18.78.
- Volume was 25.33K shares, 1.2x its 50-day average of 21.24K.
- Price is -7.1% vs its 50-day average ($19.92).
- 52-week range $17.96–$20.91; today's close sits at 18% of that range, 11.5% below the 52-week high.
Oct 5, 2026 — TCBIO ends flat (-0.1%) to $18.88
- Closed at $18.88, -0.13% vs the prior close of $18.90. Day range $18.72–$18.98, opened at $18.80.
- Volume was 11.79K shares, 0.6x its 50-day average of 21.07K — lighter than usual.
- Price is -5.4% vs its 50-day average ($19.96).
- 52-week range $17.96–$20.91; today's close sits at 31% of that range, 9.7% below the 52-week high.
Oct 2, 2026 — TCBIO rises 0.5% to $18.90
- Closed at $18.90, +0.48% vs the prior close of $18.81. Day range $18.75–$19.10, opened at $18.84.
- Volume was 12.95K shares, 0.6x its 50-day average of 21.19K.
- Price is -5.5% vs its 50-day average ($19.99).
- 52-week range $17.96–$20.91; today's close sits at 32% of that range, 9.6% below the 52-week high.
TCBIO latest news & SEC filings
Every SEC filing by or about TCBIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Detrich Ellen sold 2,045 shares at $100.03 (≈$204.56K) on Jul 24, 2026
- Detrich Ellen sold 2,045 shares at $100.03 (≈$204.56K) on Jul 24, 2026
- Detrich Ellen sold 2,045 shares at $100.03 (≈$204.56K) on Jul 24, 2026
- Detrich Ellen sold 2,045 shares at $100.03 (≈$204.56K) on Jul 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 24, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 23, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $84.95M (prior year $77.33M) (+9.9% vs Jun 30, 2025)
- Diluted EPS: $1.83 (prior year $1.58) (+15.8% vs Jun 30, 2025)
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TCBIO
- Last results release: Jul 22, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Jan 22, 2026, Oct 22, 2025. Based on that rhythm, the next report is likely around Oct 21, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.64% (largest 7.3%).
- Liquidity: about 23.01K shares (≈$413.70K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $17.98 vs a range of $17.30–$20.91 (19% of the range).
- Dividends: last ex-dividend date Sep 1, 2026 ($0.3594/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 9 open-market buys, 16 sales; latest: Ellen Detrich sold 2,045 shares on Jul 24, 2026.
- Latest filings: 8-K Sep 16, 2026; 8-K Sep 14, 2026; 10-Q Jul 23, 2026.
- Share count: 43.47M shares outstanding (Jul 21, 2026), -5.0% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: State Commercial Banks.
TCBIO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.50 | 18.06 | 17.30 | 17.98 | 6.57K |
| Oct 14, 2026 | 18.25 | 19.39 | 17.41 | 19.39 | 4.91K |
| Oct 13, 2026 | 18.00 | 18.30 | 17.95 | 18.30 | 1.21K |
| Oct 12, 2026 | 18.10 | 18.45 | 18.00 | 18.12 | 1.27K |
| Oct 9, 2026 | 18.26 | 18.26 | 18.10 | 18.25 | 7.85K |
| Oct 8, 2026 | 18.14 | 19.24 | 18.14 | 18.51 | 1.45K |
| Oct 7, 2026 | 18.45 | 18.45 | 18.07 | 18.28 | 24.57K |
| Oct 6, 2026 | 18.78 | 19.05 | 18.47 | 18.50 | 25.33K |
| Oct 5, 2026 | 18.80 | 18.98 | 18.72 | 18.88 | 11.79K |
| Oct 2, 2026 | 18.84 | 19.10 | 18.75 | 18.90 | 12.95K |
| Oct 1, 2026 | 18.35 | 18.85 | 18.30 | 18.81 | 35.86K |
| Sep 30, 2026 | 18.58 | 18.82 | 18.23 | 18.40 | 96.34K |
| Sep 29, 2026 | 18.32 | 18.65 | 17.96 | 18.54 | 47.47K |
| Sep 28, 2026 | 18.64 | 18.64 | 18.25 | 18.35 | 35.59K |
| Sep 25, 2026 | 18.85 | 19.00 | 18.60 | 18.64 | 33.47K |
| Sep 24, 2026 | 18.90 | 19.20 | 18.79 | 18.86 | 15.94K |
| Sep 23, 2026 | 19.22 | 19.54 | 18.70 | 18.97 | 35.53K |
| Sep 22, 2026 | 19.55 | 19.59 | 19.06 | 19.27 | 27.76K |
| Sep 21, 2026 | 19.54 | 19.75 | 19.41 | 19.50 | 20.06K |
| Sep 18, 2026 | 19.68 | 19.75 | 19.45 | 19.72 | 14.26K |
About Texas Capital Bancshares
Texas Capital Bancshares (TCBIO) is listed on the Nasdaq and classified by the SEC under “State Commercial Banks”. Its business address is in DALLAS, TX. Fiscal year ends December 31. SEC CIK 1077428.
TCBIO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Paola M Arbour | Director | Apr 29, 2026 |
| Jonathan Baliff | Director | Apr 29, 2026 |
| Ranjana B Clark | Director | Apr 29, 2026 |
| David S. Huntley | Director | Apr 29, 2026 |
| Charles S Hyle | Director | Apr 23, 2026 |
| Thomas E Long | Director | Apr 29, 2026 |
| Mark W Midkiff | Director | Apr 29, 2026 |
| Steve Rosenberg | Director | Apr 29, 2026 |
| Elysia Holt Ragusa | Director | Apr 23, 2026 |
| Robert W Stallings | Director | Apr 23, 2026 |
| Dale W Tremblay | Director | Apr 29, 2026 |
| Laura L Whitley | Director | Apr 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Anna M Alvarado | Chief Legal Officer | Aug 20, 2026 |
| John W Cummings | Chief Administrative Officer | Feb 17, 2026 |
| Ellen Detrich | Controller | Jul 27, 2026 |
| Rob C Holmes | Chairman, President and CEO | Jun 8, 2026 |
| David W Oman | Chief Risk Officer | Jul 6, 2026 |
| John Matthew Scurlock | Chief Financial Officer | Jun 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 24, 2026 | Ellen Detrich | Sale | 2,045 | $100.03 |
| Jul 24, 2026 | Ellen Detrich | Sale | 2,045 | $100.03 |
| Jul 24, 2026 | Ellen Detrich | Sale | 2,045 | $100.03 |
| Jul 24, 2026 | Ellen Detrich | Sale | 2,045 | $100.03 |
| Jun 15, 2026 | John Matthew Scurlock | Buy | 44 | $101.29 |
| Jun 15, 2026 | John Matthew Scurlock | Buy | 44 | $101.29 |
| Jun 15, 2026 | John Matthew Scurlock | Buy | 44 | $101.29 |
| Jun 15, 2026 | John Matthew Scurlock | Buy | 44 | $101.29 |
| Jun 9, 2026 | Anna M Alvarado | Sale | 3,500 | $100.95 |
| Jun 9, 2026 | Anna M Alvarado | Sale | 3,500 | $100.95 |
| Jun 9, 2026 | Anna M Alvarado | Sale | 3,500 | $100.95 |
| Jun 9, 2026 | Anna M Alvarado | Sale | 3,500 | $100.95 |
| Jun 8, 2026 | Rob C Holmes | Sale | 49,500 | $101.22 |
| Jun 8, 2026 | Rob C Holmes | Sale | 49,500 | $101.22 |
| Jun 8, 2026 | Rob C Holmes | Sale | 49,500 | $101.22 |
TCBIO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $330.24M | 6.79 | $360.15M |
| Dec 31, 2024 | — | $77.51M | 1.28 | $480.09M |
| Dec 31, 2023 | — | $189.14M | 3.54 | $373.74M |
| Dec 31, 2022 | — | $332.48M | 6.18 | $147.97M |
| Dec 31, 2021 | — | $253.94M | 4.60 | $657.32M |
Latest balance sheet: total assets $33.91B, total liabilities $30.27B, cash $4.43B (as of Jun 30, 2026).
TCBIO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 22, 2026 | 8-K Item 2.02 (results) | $20.50 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | — |
| Jan 22, 2026 | 8-K Item 2.02 (results) | — |
| Oct 22, 2025 | 8-K Item 2.02 (results) | — |
| Jul 17, 2025 | 8-K Item 2.02 (results) | — |
| Apr 17, 2025 | 8-K Item 2.02 (results) | — |
| Jan 23, 2025 | 8-K Item 2.02 (results) | — |
| Oct 17, 2024 | 8-K Item 2.02 (results) | — |
| Jul 18, 2024 | 8-K Item 2.02 (results) | — |
| Apr 18, 2024 | 8-K Item 2.02 (results) | — |
| Jan 18, 2024 | 8-K Item 2.02 (results) | — |
| Oct 19, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · State Commercial Banks
Bank of New York Mellon (BNY)State Street (STT)Fifth Third Bancorp (FITB)Itau Unibanco (ITUB)Citizens Financial (CFG)M&T Bank (MTB)Northern (NTRS)Bank Bradesco (BBD)Bank Of Nova Scotia (BNS)Ally Financial (ALLY)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TCBIO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.